US Stock MarketDetailed Quotes

UCBJF UCB S.A.

Watchlist
  • 178.500
  • 0.0000.00%
15min DelayClose Sep 3 16:00 ET
33.86BMarket Cap132.91P/E (TTM)

About UCB S.A. Company

UCB SA engages in the research and development of biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.

Company Profile

SymbolUCBJF
Company NameUCB S.A.
Founded1925
CEOMr. Jean-Christophe Tellier
MarketPink Market
Employees8703
Fiscal Year Ends12-31
AddressAllée de la Recherche, 60
CityBrussels
ProvinceBrussels Region
CountryBelgium
Zip Code1070
Phone32-2-559-99-99
Websitehttp://www.ucb.com

Company Executives

  • Name
  • Position
  • Salary
  • Jean-Christophe Tellier
  • Director and Chief Executive Officer
  • --
  • Fiona du Monceau
  • Vice Chairman of the Board
  • --
  • Jonathan M. Peacock
  • Chairman of the Board
  • --
  • Cedric van Rijckevorsel
  • Director
  • --
  • Charles-Antoine Janssen
  • Director
  • --
  • Cyril Janssen
  • Director
  • --
  • Albrecht De Graeve
  • Director
  • --
  • Susan Gasser
  • Independent Director
  • --
  • Maelys Castella
  • Independent Director
  • --
  • Kay Davies
  • Independent Director
  • --
  • Ulf Wiinberg
  • Independent Director
  • --
  • Pierre Gurdjian
  • Independent Director
  • --
  • Dr. Jan Berger
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg